Platelet Rich Plasma, Complex Decongestive Physiotherapy and Low Level Laser in Treatment of Lower Extremity Lymphoedema
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03080207|
Recruitment Status : Completed
First Posted : March 15, 2017
Last Update Posted : March 19, 2019
At the end of the study, comparative information about the effects of PRP, complex decongestive physiotherapy and low level laser on edema volume, range of motion, muscle strength, functional capacity and quality of life will be obtained in the treatment of patients with lower limb lymphedema.
Since there is no study about this field in the literature, this study will provide new and valuable contributions about treatment of lower extremity lymphedema for the researchers and clinicians.
|Condition or disease||Intervention/treatment||Phase|
|Lower Extremity Lymphedema||Procedure: PRP method Procedure: Low Level Laser Procedure: Complex Decongestive Physiotherapy||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||45 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Comparison of Efficacy of Platelets / Platelet Enriched Plasma Regard (PRP) Method, Complex Decongestive Physiotherapy and Low Level Laser in Treatment of Lower Extremity Lymphoedema|
|Actual Study Start Date :||January 17, 2017|
|Actual Primary Completion Date :||August 1, 2017|
|Actual Study Completion Date :||January 1, 2018|
|Experimental: Platelets / Platelet Enriched Plasma Regard (PRP) Method||
Procedure: PRP method
It will first be placed on a 25 cc venous blood centrifuge in anticoagulated tubes containing acid citrate dextrose (ACD), and autologous venous blood will be centrifuged at 3200 rpm for 15 minutes. Using the PRP kit, the plasma rich in platelet volume of about 3 cc volume will be removed. This will be activated by the addition of platelet agonists such as thrombin, calcium gluconate or calcium chloride. Injections should be administered subcutaneously for 2-3 weeks, 3-4 times for inguinal, popliteal region and ankle for a total of 12 weeks. Also, all patients in this groups have received Complex Decongestive Physiotherapy (Manual lymph drainage (MLD), skin care, compression therapy and active therapeutic exercise).
|Experimental: Complex Decongestive Physiotherapy||
Procedure: Low Level Laser
Low Density Laser treatment will be applied for the first 4 weeks every 12 weeks, the remaining 8 weeks 2 days / week. A total of 9 regions (6 point inguinal region and 3 points popliteal region) are to be applied by applying the laser head close to the skin (20000 Hz, 1.5 J / cm2) with the laser device and the regions where lymph nodes and lymph pathways are dense.
During the application, the patient will be in the supine position for the popliteal region, with the patient in the supine position for the inguinal region and the legs free in the abdomen.Also, all patients in this groups have received Complex Decongestive Physiotherapy (Manual lymph drainage (MLD), skin care, compression therapy and active therapeutic exercise).
|Experimental: Low Level Laser||
Procedure: Complex Decongestive Physiotherapy
Complex Decongestive Physiotherapy (CDP) consists of four basic components and two phases. Four basic components; Manual lymph drainage (MLD), skin care, compression therapy and therapeutic exercise. Phase I (intense phase): It is also referred to as the phase of reducing the remission. In this phase, skin care and compression bandages are renewed after daily MLD application. The patient is taught how to bandage on his own. (Phase I, 4 weeks) The duration of phase I may vary according to the patient. In Phase II, MLD can be administered 2 or 3 times per week depending on the needs of the individual. In this case, the patient is followed by home program. Our cases will be treated in Phase I every day for 12 weeks in total and 2 days / week in Phase II according to KBF phases. All patients in this group have received only Complex Decongestive Physiotherapy.
- Health-related quality of life [ Time Frame: 12 weeks ]
- Lower-extremity-circumference [ Time Frame: 12 weeks ]
- Numeric rating scale [ Time Frame: 12 weeks ]
- 6 minutes walking test [ Time Frame: 12 weeks ]
- Tissue dielectric constant Questionnaire [ Time Frame: 12 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03080207
|Istanbul University Faculty of Health Science|
|Istanbul, Turkey, 34740|
|Principal Investigator:||Ahmet Akgul, Prof.Dr.||Istanbul University|
|Study Director:||Ela Tarakci, Assoc.Dr.||Istanbul University|
|Study Director:||Nilay Arman, PhD, PT||Istanbul University|
|Study Director:||Tugba Civi, PT||Istanbul University|
|Study Director:||Musa Cirak, MD, DR||Bakirkoy Dr.Sadi Konuk Education and Research Hospital|